NIH-funded research Fellowship grant

Understanding how Klotho affects artery calcification in heart and metabolic diseases

Official title: Cardiometabolic disease and vascular aging: Klotho regulation of medial arterial calcification

Funded at University of California, San Francisco · NIH-10998418 · Data updated 2026-11-12

This study is looking at how a protein called Klotho affects blood vessel health in people with peripheral artery disease, especially those with diabetes or kidney issues, to better understand why some patients develop serious problems like artery hardening and limb amputation, and to find new ways to help prevent these issues.

More Aging research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$79,756
NIH project number1F32HL176076-01
Project IDNIH-10998418 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with peripheral artery disease, particularly those experiencing chronic limb-threatening ischemia.

Less likely to help

Patients without peripheral artery disease or those not experiencing vascular calcification may not benefit from this research.

What this research studies

This research investigates the role of Klotho, a protein that regulates insulin and phosphate levels, in the development of medial artery calcification (MAC) associated with peripheral artery disease (PAD). The study aims to understand how conditions like diabetes and renal disease contribute to vascular calcification, particularly in patients with chronic limb-threatening ischemia (CLTI). By analyzing tissue and serum samples from patients, the research seeks to uncover the molecular changes that occur in the arteries and how these changes may lead to complications such as limb amputation. The findings could provide insights into potential therapeutic targets for preventing or treating vascular calcification.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reduce vascular calcification, improving outcomes for patients with PAD.

How similar studies have gone: Previous research has shown promising results in understanding vascular calcification mechanisms, but this specific approach focusing on Klotho regulation is relatively novel.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Liu, Iris — University of California, San Francisco
  • Study coordinator: Liu, Iris

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.